Attaching great importance to corporate governance and pursuing sustainable growth and ethical management, Oneness Biotech continues to strengthen the corporate governance structure with an effective internal control system and adheres information transparency. In 2020, the Company appointed the “Human Resource Department” as the unit of ethical management. The department is responsible for the formulation and implementation supervision of the ethical management policy and the related preventive solutions. It shall provide education and training courses regarding ethical management and the prevention of corruption and insider trading. It shall, at least once a year, report to the Board of Directors about how the ethical management policy and solutions for preventing unethical conduct have been executed in that year.
On September 30, 2020, the Board of Directors approved that Chih-Hui Cheng, the current General Manager of Oneness Biotech and former Deputy General Manager of the Company’s Finance Department, serves as the Corporate Governance Officer, who is responsible for affairs related to corporate governance, safeguarding shareholders’ rights and interests, and strengthening the functions of the Board of Directors. The Corporate Governance Office shall also propagate the Ethical Corporate Management Best Practice Principles and the related regulations to the members of the Board of Directors.
Report on the Implementation of the Ethical Management Policy
1. Arranged by the Finance Department, Directors took part in forums related to corporate governance during August and September 2021 in order to expand their professional views on sustainable development of the Company and ethical management.
2. When getting onboard, for duty, new recruits receive education and training on the Ethical Corporate Management Best Practice Principles. Policies related to ethical management are announced as early as new employee orientation in order for employees to understand the Company’s Ethical Management Policy and the related regulations.
3. Education and training on the Ethical Management Policy are conducted annually. In 2021, education and training were carried out to all employees in August on the topic “Employees’ IP concept and the protection of trade secrets”, and in September on the topic “Ethical management, corporate governance, and corporate social responsibility: a case study of the three major principles”. During the courses, actual cases were used to strengthen the concept of ethical management, to encourage the management and prevention of unethical conduct, and to emphasize the obligation of confidentiality concerning the Company’s intellectual property. To ensure that all the employees know and follow the related laws and regulations, an examination was applied to all. Only those with a score of 80 or above were deemed as passing the examination. A total of 274 employees were trained, with the total training hours of 403 hours.
4. The contents of the education and training course on the Ethical Management Policy are available on the internal training website for employees to receive make-up training or be retrained at any time, so the related concepts and matters that must follow can be propagated and emphasized to employees.
Prevention of Insider Trading
Oneness Biotech has established the "Regulations for Prevention of Insider Trading", which specifies the scope of application, the people and matters being regulated, and the related operating procedures. The regulation is intended to prevent Directors, managerial officers, and other insiders from violating regulations related to insider trading either accidentally due to ignorance of such regulations or intentionally, in order to protect investors’ and the Company’s rights and interests.
Oneness Biotech has also adopted the “Whistleblowing Regulations”. According to the above, a whistleblower may report to the Company through reporting channels such as email (ONENESS_Audit@onenessbio.com.tw) and regular mail. The regulation further specifies the reporting process, protection of the reported data, punitive measures, and an award system for whistleblowers. Ethical related policies, explanations, and operating results are periodically disclosed in the ESG Report and on the Company’s website.